Empagliflozin’s role in reducing ventricular repolarization heterogeneity: insights into cardiovascular mortality decline from the EMPATHY-HEART trial

Abstract Background The incidence of myocardial infarction (MI) and sudden cardiac death (SCD) is significantly higher in individuals with Type 2 Diabetes Mellitus (T2DM) than in the general population. Strategies for the prevention of fatal arrhythmias are often insufficient, highlighting the need...

Full description

Bibliographic Details

Published in:	Cardiovascular Diabetology
Main Authors:	Cristiane Lauretti, Graziella L. Antonio, Ariana E. Fernandes, Fernando G. Stocco, Adriana C. C. Girardi, Richard L. Verrier, Bruno Caramelli
Format:	Article
Language:	English
Published:	BMC 2024-06-01
Subjects:	Type 2 diabetes Mellitus Coronary heart disease Empagliflozin T-wave heterogeneity Ventricular Arrhythmias Cardiovascular mortality
Online Access:	https://doi.org/10.1186/s12933-024-02311-1